News

Overuse and misuse of antibiotics has led to a public health crisis-a crisis we must pay attention to now, according to a report that will be published in the August issue of Consumer Reports.

FDA has approved Aurobindo’s entacapone tablets USP, 200 mg, the generic equivalent to Novartis’ Comtan tablets 200 mg.

Coverage decisions about new technologies, including access and cost considerations, are a major challenge for public and private payers.

How does your health system compare to others when it comes to new initiatives? Recent survey findings from HFMA might provide some answers.

How do we reverse the trend of super users and reduce costs for this small, unique pool of members? Here are some tips.

Stuart M. Gerson, member of Epstein Becker Green's Litigation and Health Care & Life Sciences practices, discusses four possible consequences of the King v. Burwell ruling.

Health plans, exchanges and associations share their reactions to the Supreme Court's King V. Burwell ruling.

As lipid management in the United States under goes transition in response to new guideline recommendations and expanding lipid-lowering therapy options, the Duke Clinical Research Institute (DCRI) announced a new study to better understand contemporary lipid management as well as the beliefs and attitudes of patient and providers regarding cholesterol, cardiovascular risk assessment, and options for lipid treatments.

While sales of Gilead Science’s popular hepatitis C drug, Harvoni, had been performing well for several months, the trend has reversed of late. Hepatitis C drug Sovaldi, also from Gilead, has also hit some bumps in the road – in both the U.S. and China.

Antibiotic resistance is a growing problem, both in the United States and across the world. The main driving factors behind antibiotic resistance are the overuse and misuse of antibiotics, according to the Centers for Disease Control and Prevention.

Here are 5 drug categories that may command the most impact on pharma spending in the near future.

Rep. Steve Stivers (R-Ohio) and Rep. Peter Welch (D-Vt.) have re-introduced the Fair Access for Safe and Timely (FAST) Generics Act to what they say will increase consumer access to generic drugs, boost market competition and ultimately save consumers money.

A new, painless “smart insulin patch” lowered blood glucose in a mouse model of type 1 diabetes for up to 9 hours, according to a study published in the Proceedings of the National Academy of Sciences.

It can be challenging for executives to understand and keep up with rapidly evolving technology terms. Here's help.

Creating buy-in among hospital physicians when embarking on a new technology initiative can be difficult. Here are some tips.

Mobile devices are becoming a very real part of the healthcare journey. Are your physicians making the most of their capabilities?

More adults than children in the United States now take medication for attention deficit hyperactivity disorder (ADHD), according to new data.

Patients to assist insurer, association in creating program to ensure its relevancy and practicality for those with diabetes.

The Institute for Safe Medication Practices (ISMP) is cautioning hospital pharmacists and other healthcare professionals about the intravenous cancer medication fluorouracil.

Global prescription drug sales should reach nearly $1 trillion by 2020, thanks in part to FDA approvals of breakthrough drugs for cancer, hepatitis C and other diseases, a new report finds.

The Food and Drug Administration (FDA) and PatientsLikeMe will work together to determine how patient-reported data can give new insights into drug safety.

Infants and children who are given prescription acid-reducing medications face a substantially higher risk of developing Clostridium difficile infection, according to a study published recently in the online edition of Clinical Infectious Diseases.

Synergy Pharmaceuticals’ drug for chronic idiopathic constipation (CIC) has garnered very positive results in a phase 3 clinical trial, the company reported this week.

A large chunk of what insurers spend can be saved by improving medication adherence through medication therapy management done right.

Any day now, the Supreme Court will decide the highly anticipated King v. Burwell, which will determine the viability of a central mechanism of the Affordable Care Act.

Once-weekly dulaglutide is an effective treatment option for patients with type 2 diabetes who need to advance to injectable therapy, according to results from a Japanese study presented at the 2015 American Diabetes Association Scientific Sessions in Boston

A summary of five FDA actions taken within the last few weeks.

The FDA’s Pulmonary-Allergy Drugs Advisory Committee recently recommended approval of GlaxoSmithKline Plc's drug mepolizumab (Nucala) for severe asthma patients 18 and older.